Stock listing
NASDAQ:HARP Harpoon Therapeutics Inc Stock
Follow Harpoon Therapeutics Inc into a list and get an email when it puts out news.
Last close · NASDAQ:HARP
$23.01 USD
Close on Mar 11, 2024 · No longer trades
- Lowest – highest close
- $3.29 – $23.01 USDSince Sep 5, 2023 · lowest Oct 10, 2023 · highest Mar 8, 2024
Delisted NASDAQ:HARP no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:HARP
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Harpoon Therapeutics Inc on 6ix
- Decks
- 8 decks · latest Jan 26, 2024
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Technical Presentation (January 2024) | Technical | 12 slides | Jan 26, 2024 |
| ESMO 2023 | Conference | 15 slides | Oct 23, 2023 |
| Corporate Update (December 2022) | Corporate update | 22 slides | Dec 12, 2022 |
| Investor Presentation (January 2022) | Investor deck | 40 slides | Jan 11, 2022 |
| Investor Day (December 2021) | Investor day | 38 slides | Dec 13, 2021 |
| Corporate Update (June 2021) | Corporate update | 50 slides | Jun 4, 2021 |
| Corporate Update (December 2020) | Corporate update | 30 slides | Dec 9, 2020 |
| Technical Presentation (May 2020) | Technical | 49 slides | May 29, 2020 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Alan B. Colowick Other companies: Alumis Inc. (Managing Director, AyurMaya, an affiliate of Matrix Capital Management · Since at least Jun 27, 2024); Maze Therapeutics, Inc. (Director · Jan 30, 2025 – Jan 30, 2025 · Past); Acelyrin, Inc. (Director · May 4, 2023 – May 4, 2023 · Past); Personalis, Inc. (Director · Jun 19, 2019 – May 17, 2023 · Past); Principia Biopharma Inc (Director · Sep 13, 2018 – Sep 28, 2020 · Past); Dimension Therapeutics (Director · Oct 21, 2015 – Nov 7, 2017 · Past); Achaogen Inc (Director · Mar 11, 2015 – Jun 14, 2017 · Past); Geron Corporation (President, Oncology · Oct 16, 2006 – Jan 2, 2008 · Past); Threshold Pharmaceuticals Inc (Chief Medical Officer · Mar 14, 2006 – Sep 26, 2006 · Past) | Director · Mar 24, 2021 – Apr 1, 2023 · Past |
| Georgia Erbez Other companies: Codexis, Inc. (Chief Financial Officer and Chief Business Officer · Since at least Sep 30, 2024); Coherus Oncology, Inc. (Director · Since at least Feb 20, 2024); Sierra Oncology Inc (Director · Jun 2, 2021 – Jul 1, 2022 · Past); Artelo Biosciences, Inc. (Director · Jun 21, 2019 – Aug 29, 2019 · Past); Zosano Pharma Corp (CFO and Chief Business Officer · Jun 15, 2016 – May 25, 2017 · Past); Asterias Biotherapeutics Inc (Exec VP & CFO · Nov 9, 2015 – Nov 9, 2015 · Past); Raptor Pharmaceutical Corp (Chief Financial Officer · Sep 10, 2012 – May 13, 2014 · Past) | Chief Financial Officer · Feb 7, 2019 – Jan 28, 2022 · Past |
| Luke Evnin Other companies: Werewolf Therapeutics, Inc. (Director · Since at least Dec 23, 2020); Turmeric Acquisition Corp (Chief Executive Officer · Oct 15, 2020 – Apr 30, 2021 · Past); Oncorus Inc (Director · Oct 1, 2020 – Jun 23, 2022 · Past); Syndax Pharmaceuticals, Inc. (Director · Mar 2, 2016 – May 23, 2018 · Past); Pacira BioSciences, Inc. (Director · Feb 2, 2011 – Jun 12, 2013 · Past); ReShape Lifesciences Inc (Director · Nov 14, 2007 – May 7, 2014 · Past); Restore Medical Inc (Director · May 16, 2006 – Jul 16, 2008 · Past) | Director · Nov 9, 2018 – May 28, 2020 · Past |
| Scott Myers Other companies: Zentalis Pharmaceuticals, Inc. (Chairperson · Since at least Nov 13, 2024); Dynavax Technologies Corporation (Director · Since at least Oct 19, 2021); Viridian Therapeutics, Inc. (Chief Executive Officer, Director · Feb 6, 2023 – Apr 12, 2023 · Past); Trillium Therapeutics Inc (Director · Apr 28, 2021 – Nov 17, 2021 · Past); AMAG Pharmaceuticals Inc (President & CEO, Director · Apr 28, 2020 – Nov 16, 2020 · Past); Cartesian Therapeutics, Inc. (Director · Jun 14, 2019 – Nov 13, 2023 · Past); Cascadian Therapeutics Inc (President and CEO, Director · Apr 4, 2016 – Mar 9, 2018 · Past) | Director · Feb 7, 2019 – Mar 11, 2024 · Past |
| Julia Marie Eastland Other companies: Zentalis Pharmaceuticals, Inc. (CEO & President, Director · Since at least Nov 13, 2024); Lantheus Holdings, Inc. (Director · Since at least Sep 3, 2024); CalciMedica, Inc. (Director · Sep 24, 2020 – Mar 23, 2023 · Past); Dynavax Technologies Corporation (Director · Jul 17, 2020 – May 23, 2024 · Past); Cascadian Therapeutics Inc (CFO & CBO · Sep 7, 2010 – Mar 9, 2018 · Past) | President and CEO, Director · Feb 7, 2019 – Mar 11, 2024 · Past |
| Lauren P. Silvernail Other companies: Dynavax Technologies Corporation (Director · Since at least Feb 3, 2025); Harrow, Inc. (Member, Board of Directors, Independent Director · Since at least Jan 26, 2024); Evolus, Inc. Common Stock (See Remarks · May 29, 2018 – May 17, 2022 · Past); Revance Therapeutics, Inc. (CFO & CBO · Feb 5, 2014 – May 22, 2018 · Past); Ista Pharmaceuticals Inc (CFO & VP Corporate Development · Feb 16, 2006 – Jun 6, 2012 · Past) | Director · Sep 15, 2022 – Mar 11, 2024 · Past |
| Ronald Hunt Other companies: Rallybio Corporation (Director · Since at least Jul 28, 2021); Neuronetics, Inc. (Director · Jun 27, 2018 – Apr 1, 2019 · Past); Relypsa Inc (Director · Nov 14, 2013 – Nov 14, 2013 · Past); Durata Therapeutics Inc (Director · Jul 18, 2012 – May 21, 2014 · Past) | Director · Nov 9, 2018 – Mar 8, 2024 · Past |
| James B. Bucher Other companies: Zentalis Pharmaceuticals, Inc. (Chief Legal Officer and Corporate Secretary · Since at least Aug 26, 2025); Climb Bio, Inc. (EVP and General Counsel · Aug 9, 2021 – Oct 31, 2022 · Past); Alder BioPharmaceuticals Inc (EVP & General Counsel · Jan 18, 2016 – Oct 22, 2019 · Past) | Chief Legal Officer · Dec 21, 2023 – Mar 11, 2024 · Past |
| Joanne L Viney Other companies: Sionna Therapeutics, Inc. (Director · Since at least Feb 6, 2025); LENZ Therapeutics, Inc. (Director · Jun 24, 2021 – Jul 19, 2023 · Past); Pandion Therapeutics Inc (See Remarks · Jul 16, 2020 – Apr 1, 2021 · Past) | Director · Jul 1, 2020 – Apr 1, 2023 · Past |
| Jonathan G Drachman Other companies: Neurogene Inc. (President and CEO, Director · Aug 8, 2019 – Aug 2, 2022 · Past); Calithera Biosciences, Inc. (Director · Oct 1, 2014 – Nov 10, 2021 · Past); Seagen Inc (CMO & EVP, R & D · Oct 1, 2013 – Mar 20, 2018 · Past) | Director · Feb 7, 2019 – Mar 8, 2024 · Past |
All 20 people
| Person | Seat |
|---|---|
| Luke Walker Other companies: Context Therapeutics Inc. (Independent Director · Since at least Sep 4, 2024); Zentalis Pharmaceuticals, Inc. (Director · Since at least May 24, 2024); Cascadian Therapeutics Inc (SVP, Clinical Development · Mar 9, 2017 – Mar 9, 2018 · Past) | Chief Medical Officer · Oct 3, 2022 – Mar 11, 2024 · Past |
| Mark Chin Other companies: Disc Medicine, Inc. (Director · Since at least Dec 29, 2022); Pyxis Oncology, Inc. (Director · Oct 7, 2021 – Mar 31, 2022 · Past); Enliven Therapeutics, Inc. (Director · Mar 11, 2020 – Jun 2, 2022 · Past) | Director · Nov 9, 2018 – Mar 8, 2024 · Past |
| Natalie Sacks Other companies: Caribou Biosciences, Inc. (Partner at Novo Holdings Ventures Investment · Since at least Jul 22, 2021); Zymeworks Inc. (Director · Jan 1, 2019 – Dec 21, 2022 · Past); Aduro Biotech Inc (Chief Medical Officer · Aug 31, 2016 – Sep 12, 2018 · Past) | Chief Medical Officer · Feb 7, 2019 – Jan 28, 2022 · Past |
| Andrew Robbins Other companies: Cogent Biosciences, Inc. (Chief Executive Officer & President · Since at least Oct 23, 2020); Turmeric Acquisition Corp (Director · Oct 15, 2020 – Oct 15, 2020 · Past) | Director · Mar 28, 2020 – Mar 11, 2024 · Past |
| Gerald PhD McMahon Other companies: Celldex Therapeutics, Inc. (Director · Dec 14, 2016 – Dec 3, 2018 · Past); Oncotelic Therapeutics Inc (Director · Sep 2, 2011 – Jun 1, 2016 · Past) | President and CEO, Director · Feb 7, 2019 – Jan 28, 2021 · Past |
| Patrick Baeuerle Other companies: Cullinan Therapeutics, Inc. (Chief Scientific Officer · Jan 7, 2021 – Feb 17, 2023 · Past); Tcr2 Therapeutics Inc (Director · Feb 13, 2019 – Dec 10, 2020 · Past) | Director · Feb 7, 2019 – May 28, 2020 · Past |
| Vijay K Lathi Other companies: iRhythm Holdings, Inc. (Director · Oct 19, 2016 – Mar 8, 2018 · Past) | Director · Mar 11, 2024 – Mar 11, 2024 · Past |
| Frank J Lanza | Principal Fin. & Acctng Ofc. · Sep 15, 2022 – Mar 11, 2024 · Past |
| Holger Wesche | Chief Scientific Officer · Feb 7, 2019 – Jan 28, 2022 · Past |
| Joseph S Bailes | Director · Mar 29, 2020 – Mar 11, 2024 · Past |
Log in to ask 6ix AI your own questions about Harpoon Therapeutics Inc.